CompBioMed is a user-driven Centre of Excellence in Computational Biomedicine, to nurture and promote the uptake and exploitation of high performance computing within the biomedical modelling community: academia, industry and clinical practice. European project funded by H2020 for the period 2016-2019.
The european project TransQST: Translational Quantitative Systems Toxicology aims to develop novel computational approaches using the best available data from the public and private domains to address the problems of drug safety. Funded by IMI2 for the period 2017-2021.
European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment. European project funded by H2020 for the period 2017-2021.
The aim of the project ELIXIR-EXCELERATE is to accelerate the implementation of Europe's life-science data infrastructure. European project funded by H2020 for the period 2015-2019.
The project EU-ToxRisk: "an integrated european 'flagship' program driving mechanism-based toxicity testing and risk assessment for the 21st century" is a H2020 supported collaborative project for the period 2016-2021 in which academia joins forces with small and medium-sized enterprises (SMEs), large industry, contract research organisations (CROs) and regulatory bodies to achieve a paradigm shift in toxicology towards a more efficient and animal-free chemical safety assessment.
The project MedBioinformatics "Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities" aims to develop useful bioinformatics tools and applications, and autonomously usable for analysing the huge amount of data and knowledge generated in healthcare and biomedical research in order to facilitate translational research and precision medicine. European project funded by H2020 for the period 2015-2018 and coordinated by the GRIB.
The project iPIE: "Intelligence Led Assessment of Pharmaceuticals in the Environment", aims to develop a predictive framework that utilise existing information and in silico models to support more intelligent environmental testing of pharmaceuticals in development and to prioritise legacy pharmaceuticals for full environmental risk assessment and/or environmental (bio) monitoring. European project funded by IMI for the period 2015-2017.
Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities. European project funded by IMI, extended until 2016 and coordinated by the GRIB. The eTOX project aims to develop a drug safety database from the pharmaceutical industry legacy toxicology reports and public toxicology data, innovative in silico strategies and novel software tools to better predict the toxicological profiles of small molecules in early stages of the drug development pipeline.
The Open Pharmacological Concepts Triple Store project (Open PHACTS) will develop an open access innovation platform, called Open Pharmacological Space (OPS), via a semantic web approach. OPS will be comprised of data, vocabularies and infrastructure needed to accelerate drug- oriented research. The aim is to develop an enabling resource for drug discovery projects which is open to all users and freely available in the public domain. This european project is funded by IMI and has been recently extended until 2016.
The EMIF project aims to develop a common information framework of patient-level data that will link up and facilitate access to diverse medical and research data sources, opening up new avenues of research for scientists. To provide a focus and guidance for the development of the framework, the project will focus initially on questions relating to obesity and Alzheimer’s disease. EMIF is a European project funded by IMI.